Letermovir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Letermovir
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Jinan Tantu Chemicals Letermovir

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Letermovir

Contact Supplier

pharmacompass-2-m-2025-08-25

Letermovir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 6 USDMF, 1 EU WC, 2 KDMF, 1 NDC API, 11 Listed Suppliers, $ API Reference Price

15 API Suppliers
6 USDMF
1 EU WC
2 KDMF
1 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

INTERMEDIATES

16 Intermediate Suppliers

16 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 8 FDA Orange Book, 4 Europe, 4 Canada, 2 South Africa

18 FDF Dossiers
8 FDA Orange Book
4 Europe
4 Canada
2 South Africa

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 2 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

1 SPI Pharma
3 DKSH
5 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Kirsch Pharma
2 Actylis
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
5 DFE Pharma
5 Gangwal Chemicals
1 Ideal Cures
1 Ingredion Pharma Solutions
10 Kerry
2 Keval Exports
9 Microlex e.U
2 Nitika Pharmaceutical Specialities
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
14 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
3 Silverline Chemicals
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 13 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 11 Thickeners and Stabilizers, 10 Lubricants & Glidants, 8 Co-Processed Excipients, 7 Coating Systems & Additives, 6 Parenteral, 5 Taste Masking, 4 Film Formers & Plasticizers, 3 Solubilizers, 3 Controlled & Modified Release, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 API Stability Enhancers, 2 Coloring Agents, 2 Rheology Modifiers

28 Fillers, Diluents & Binders
13 Disintegrants & Superdisintegrants
13 Granulation
13 Direct Compression
11 Thickeners and Stabilizers
10 Lubricants & Glidants
8 Co-Processed Excipients
7 Coating Systems & Additives
6 Parenteral
5 Taste Masking
4 Film Formers & Plasticizers
3 Solubilizers
3 Controlled & Modified Release
3 Emulsifying Agents
3 Chewable & Orodispersible Aids
2 API Stability Enhancers
2 Coloring Agents
2 Rheology Modifiers

DIGITAL CONTENT

18 News #PharmaBuzz

18 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Regulatory FDF Prices, 5 Annual Reports

1 US Medicaid Prescriptions
4 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 32 US Exclusivities, 4 Health Canada Patents

8 US Patents
32 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 9,506 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Merck Canada Inc.

filter Patent Reset all filters

4 All

01 42524069

filter Product Reset all filters

4 All

01 4LETERMOVIR

filter Dosage Reset all filters

4 All

01 2SOLUTION

02 2TABLET

filter Exp Date Reset all filters

4 All

01 42024-04-17

Lebsa Letermovir

Product Main Page

01

Merck Canada Inc.

LETERMOVIR

Pharmaconex

Not Confirmed

Merck Canada Inc.

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Brand Name : PREVYMIS

Patent Number : 2524069

Filing Date : 2004-04-17

Strength per Unit : 240 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Merck Canada Inc.

LETERMOVIR

Pharmaconex

Not Confirmed

Merck Canada Inc.

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Brand Name : PREVYMIS

Patent Number : 2524069

Filing Date : 2004-04-17

Strength per Unit : 480 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Merck Canada Inc.

LETERMOVIR

Pharmaconex

Not Confirmed

Merck Canada Inc.

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Brand Name : PREVYMIS

Patent Number : 2524069

Filing Date : 2004-04-17

Strength per Unit : 20 mg / mL (240 mg / 12 mL vial)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Merck Canada Inc.

LETERMOVIR

Pharmaconex

Not Confirmed

Merck Canada Inc.

Country

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Brand Name : PREVYMIS

Patent Number : 2524069

Filing Date : 2004-04-17

Strength per Unit : 20 mg / mL (480 mg / 24 mL vial)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2024-04-17

Date Granted : 2011-11-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!